摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-6-氟吡啶 | 1597-32-6

中文名称
2-氨基-6-氟吡啶
中文别名
6-氟-2-氨基吡啶
英文名称
6-fluoro-pyridin-2-ylamine
英文别名
6-fluoropyridin-2-amine;2-amino-6-fluoropyridine;6-fluoro-2-pyridinamine;6-fluoro-2-aminopyridine
2-氨基-6-氟吡啶化学式
CAS
1597-32-6
化学式
C5H5FN2
mdl
MFCD04114200
分子量
112.107
InChiKey
UZALKVXCOUSWSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    59-61°C
  • 沸点:
    225.0±20.0 °C(Predicted)
  • 密度:
    1.257±0.06 g/cm3(Predicted)
  • 溶解度:
    溶于甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.9
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 危险品运输编号:
    NONH for all modes of transport
  • 海关编码:
    2933399090
  • 危险标志:
    GHS05,GHS07
  • 危险性描述:
    H302,H315,H318,H335
  • 危险性防范说明:
    P261,P280,P305 + P351 + P338
  • 储存条件:
    室温环境下。

SDS

SDS:4c311e3496b3839b8adfb7747d9f6db0
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 6-Fluoropyridin-2-amine
Synonyms: 2-Amino-6-fluoropyridine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H318: Causes serious eye damage
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

Section 3. Composition/information on ingredients.
Ingredient name: 6-Fluoropyridin-2-amine
CAS number: 1597-32-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H5FN2
Molecular weight: 112.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (6-Fluoropyridin-2-amine)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

简介

2-氨基-6-氟吡啶是一种有机中间体,可通过2,6-二氟吡啶与氨水的亲核取代反应制备。有文献报道该化合物可用于合成2-氟-3,6-二羟基吡啶。2-氟-3,6-二羟基吡啶是一种新型含氟吡啶类化合物。

含氟吡啶类化合物在性能上具有用量少、毒性低、药效高、代谢能力强等优点,广泛应用于抗生素合成、心血管疾病药物治疗、农用杀虫剂、杀菌剂和除草剂等领域。

制备

将2,6-二氟吡啶(50g,434mmol)溶解在氢氧化铵(200mL,28.0-30.0%)溶液中,并置于钢制封管中,在105℃下加热15小时。冷却后,将反应物在冰浴中冷却、过滤并用冷水冲洗沉淀物,干燥后得到白色固体2-氨基-6-氟吡啶(45.8g,收率94%)。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-6-氟吡啶N-溴代丁二酰亚胺(NBS) 、 sodium carbonate 作用下, 以 氯仿N,N-二甲基甲酰胺 为溶剂, 反应 28.0h, 生成 5-bromo-6-phenoxypyridin-2-amine
    参考文献:
    名称:
    [EN] TRISUBSTITUTED HETEROCYCLIC DERIVATIVES AS ROR GAMMA MODULATORS
    [FR] DÉRIVÉS HÉTÉROCYCLIQUES TRISUBSTITUÉS EN TANT QUE MODULATEURS DE ROR GAMMA
    摘要:
    本发明提供了公式(I)的三取代杂环衍生物,可能在治疗上有用,更具体地作为RORγ调节剂;其中R1、R2、R3、Ra、X、L、m和环A在规范中给出的含义,以及它们的药学上可接受的盐,在治疗和预防疾病或紊乱方面有用,特别是它们在调节RORγ受体方面具有优势的疾病或紊乱的使用。本发明还提供了化合物的制备以及包括至少一种公式(I)的三取代杂环衍生物与药学上可接受的载体、稀释剂或赋形剂的药物配方。
    公开号:
    WO2014125426A1
  • 作为产物:
    描述:
    2,6-二氟吡啶ammonium hydroxide 作用下, 125.0 ℃ 、1.4 MPa 条件下, 反应 5.0h, 以92%的产率得到2-氨基-6-氟吡啶
    参考文献:
    名称:
    大规模合成具有环12π-电子环系统的新环嗪,5-thia-1,8 b-二氮杂ena烯-3-羧酸衍生物
    摘要:
    5-thia-1,8b-二氮杂ena烯(2及其酯8)是新的环嗪,其中顺磁环存在于外围的12π电子环系统中。已经开发了三种方便的制备方法8。其中一项涉及新化合物5-氟咪唑并[1,2- a ]吡啶(6b)的巯基乙醇化反应,然后进行Duff反应,无需色谱纯化即可得到64%收率的8。
    DOI:
    10.1016/s0040-4020(01)01171-1
点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS<br/>[FR] ANALOGUES D'URÉE PONTÉS SUBSTITUÉS EN TANT QUE MODULATEURS DE SIRTUINE
    申请人:GLAXOSMITHKLINE IP NO 2 LTD
    公开号:WO2016079709A1
    公开(公告)日:2016-05-26
    The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as Sirtuin Modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.
    本发明涉及一种新型的取代桥式脲类似物化合物,其化学式为(I)或其药学上可接受的盐,相应的药物组合物,制备这种化合物的方法以及单独使用或与其他治疗剂联合使用的这些化合物作为Sirtuin调节剂,可用于增加细胞寿命,并用于治疗和/或预防各种疾病和紊乱,包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症和/或潮红有关的疾病或紊乱,以及那些会受益于增加线粒体活性的疾病或紊乱。
  • Synthesis and biological evaluation of 2-arylimino-3-pyridin-thiazolineone derivatives as antibacterial agents
    作者:Ming-Guang Cai、Yang Wu、Jun Chang
    DOI:10.1016/j.bmcl.2016.03.089
    日期:2016.5
    With an intention to find more potent antibacterial agents, four halogen disubstituted thiazolineone derivatives (2a-d), five halogen monosubstituted thiazolineone derivatives (2e-i), and eleven 2-arylimino-3-pyridin-thiazolineone derivatives (2j-t) were synthesized and screened for their antibacterial activity, bactericidal activity, cytotoxicity, and erythrocyte hemolysis. Most of the synthesized
    为了寻找更有效的抗菌剂,分别开发了四种卤素二取代的噻唑啉酮衍生物(2a-d),五个卤素单取代的噻唑啉酮衍生物(2e-i)和十一种2-芳基氨基-3-吡啶-噻唑啉酮衍生物(2j-t)。合成并筛选了它们的抗菌活性,杀菌活性,细胞毒性和红细胞溶血作用。大多数合成衍生物在抑制表皮葡萄球菌和MRSA的生长中显示出抗菌活性,并且在Vero细胞的细胞毒性研究和健康人红细胞的溶血活性试验中显示出安全性。2-Arylimino-3-pyridin-thiazolineone衍生物不仅改善了clog P,而且在抑制表皮葡萄球菌和MRSA的生长中显示出强大的抗菌活性。特别是几种化合物(2f,2i,
  • COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES
    申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    公开号:US20190211011A1
    公开(公告)日:2019-07-11
    The invention relates to compounds of formula (II) for using in imaging and particularly for the diagnosis of neurodegenerative diseases
    该发明涉及公式(II)的化合物,用于影像学,特别是用于诊断神经退行性疾病。
  • Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity
    作者:Matthew E. Voss、Matthew P. Rainka、Mike Fleming、Lisa H. Peterson、David B. Belanger、M. Arshad Siddiqui、Alan Hruza、Johannes Voigt、Kimberly Gray、Andrea D. Basso
    DOI:10.1016/j.bmcl.2012.03.051
    日期:2012.5
    The structure–activity relationships of new Aurora A/B kinase inhibitors derived from the previously identified kinase inhibitor 12 are described. Introduction of acetic acid amides onto the pyrazole of compound 12 was postulated to influence Aurora A/B selectivity and improve the profile against off-target kinases. The SAR of the acetic acid amides was explored and the effect of substitution on enzyme
    描述了源自先前鉴定的激酶抑制剂12的新型Aurora A / B激酶抑制剂的构效关系。假定将乙酰胺引入化合物12的吡唑中会影响Aurora A / B的选择性并改善针对脱靶激酶的作用。探索了乙酸酰胺的SAR,并研究了取代对酶抑制的影响以及基于机理的细胞活性。另外,筛选了几种更有效的抑制剂的脱靶激酶选择性。
  • Copper-catalyzed direct amination of benzylic hydrocarbons and inactive aliphatic alkanes with arylamines
    作者:Hua Yao、Bo Xie、Xiaoyang Zhong、Shengzhou Jin、Sen Lin、Zhaohua Yan
    DOI:10.1039/d0ob00491j
    日期:——
    A new synthetic method toward direct C-N bond formation through saturated C-H amination of benzylic hydrocarbons and inactive aliphatic alkanes with primary aromatic amines under an inexpensive catalyst/oxidant (Cu/DTBP) system has been developed. Both aminopyridines and anilines could react smoothly with primary and secondary benzylic C-H substrates or cyclohexane to form the corresponding aromatic
    在廉价的催化剂/氧化剂(Cu / DTBP)系统下,已经开发出一种新的合成方法,该方法可通过苄基烃和惰性脂肪族烷烃与伯芳族胺的饱和CH胺化直接形成CN键。氨基吡啶和苯胺均可与伯和仲苄基CH底物或环己烷顺利反应,以中等至良好的收率形成相应的芳族仲胺。该协议的优点是宽泛的官能团耐受性和使用现成的原料。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-